Description
Piroxivis Injection is a non-steroidal anti-inflammatory drug (NSAID) containing Piroxicam BP 40 mg per 2 ml ampoule. It is indicated for intramuscular (IM) or intravenous (IV) administration in patients suffering from acute musculoskeletal pain, post-operative inflammation, and flare-ups of chronic arthritis. Piroxicam inhibits prostaglandin synthesis, offering long-lasting analgesic, anti-inflammatory, and antipyretic effects.
Packaged in a box of 5 ampoules, each sealed in sterile glass to ensure pharmaceutical integrity, Piroxivis is manufactured by ANVIS in compliance with international GMP standards. Its fast absorption profile allows for prompt symptom relief in clinical and hospital settings, particularly where oral medications are contraindicated.
This formulation is ideal for short-term use under medical supervision and is commonly employed in emergency care, trauma management, and orthopedic therapy.
